Logo

Personal Genome Diagnostics: Elio Plasma Complete

Jun 01, 2021

Personal Genome Diagnostics has launched its Elio Plasma Complete assay, a next-generation sequencing (NGS) kit for comprehensive blood-based genomic analysis. The research-use-only kit analyzes circulating cell-free tumor DNA (cfDNA) for genetic alterations in cancer. The firm said the assay evaluates even low-abundance sample DNA and processes samples using a NGS panel of 521 genes. PGDx added that the kit also includes automated bioinformatics that helps identify somatic mutations within cfDNA with high sensitivity and specificity. 

Breaking News
The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.